Latest Breaking News On - Astrocyte pharmaceuticals - Page 1 : comparemela.com

Astrocyte Pharmaceuticals Raises $6M in Pre-Series B Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

United kingdomWilliam korinekAstrocyte pharmaceuticalsAlzheimer drug discovery foundationNavis vb fundDreavent capitalDrug discovery foundationDeepwork capitalMid atlantic bio angelsBoston harbor angelsLife science angelsMass medical angelsSidecar angels

Alzheimer s Drug Discovery Foundation Joins Astrocyte Pharmaceuticals $6M Pre-Series B Financing Round to Expand Development of Cerebroprotectant AST-004

Alzheimer s Drug Discovery Foundation Joins Astrocyte Pharmaceuticals $6M Pre-Series B Financing Round to Expand Development of Cerebroprotectant AST-004
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

William korinekGorka fiusRonalds lauderHoward fillitNavis vb fundAstrocyte pharmaceuticals incAstrocyte pharmaceuticalsAlzheimer drug discovery foundationPharmaceuticals incSeriesb bridgeDreavent capitalDrug discovery foundationChief science officerDrug discoveryDeepwork capitalMid atlantic bio angels

Alzheimer s Drug Discovery Foundation Joins Astrocyte Pharmaceuticals $6M Pre-Series B Financing Round to Expand Development of Cerebroprotectant AST-004

Alzheimer s Drug Discovery Foundation Joins Astrocyte Pharmaceuticals $6M Pre-Series B Financing Round to Expand Development of Cerebroprotectant AST-004
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Gorka fiusRonalds lauderWilliam korinekHoward fillitAstrocyte pharmaceuticalsAlzheimer drug discovery foundationNavis vb fundAlzheimer drug discovery foundation joins astrocyteAstrocyte pharmaceuticals incPre seriesb financing roundExpand developmentPharmaceuticals incSeriesb bridgeDreavent capitalDrug discovery foundationChief science officer

Phase 1b study will evaluate small molecule adenosine receptor agonist for stroke, TBI

Astrocyte Pharmaceuticals Inc. announced initiation of a phase 1b study of AST-004, a small molecule adenosine A3/A1 receptor agonist for stroke and traumatic brain injuries that will be evaluated in healthy volunteers.According to a release from Astrocyte, the study will assess the safety, tolerability, pharmacokinetics and pharmacodynamics of AST-004 as a loading dose followed by continuous

Elisa mannaHeather bieleAstrocyte pharmaceuticalsTechnology enterprise consortiumUs army medical researchAstrocyte pharmaceuticals incUs department of defenseMedical technology enterprise consortiumMedical researchDevelopment command

Astrocyte Announces Initiation of an Extended Infusion Phase 1B Study of AST-004 for Stroke and Traumatic Brain Injuries

Astrocyte Announces Initiation of an Extended Infusion Phase 1B Study of AST-004 for Stroke and Traumatic Brain Injuries
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesElisa mannaAmerica department of defenseClinical development operationsUs army medical researchDepartment of defenseDepartment of the armyTechnology enterprise consortiumAstrocyte pharmaceuticals incDevelopment commandAstrocyte pharmaceuticalsWall streetPharmaceuticals incVice presidentClinical developmentMedical technology enterprise consortium